Hologic, Inc. (HOLX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Marlborough, MA, United States. El CEO actual es Stephen MacMillan.
HOLX tiene fecha de IPO 1990-03-01, 7,063 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $16.97B.
Hologic, Inc. is a global medical technology company that develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical solutions focused on women's health. Operating through four business segments—Diagnostics, Breast Health, GYN Surgical, and Skeletal Health—the company offers a comprehensive portfolio including molecular diagnostic assays for infectious disease detection, advanced breast imaging and biopsy systems, minimally invasive gynecological surgical devices, and orthopedic imaging solutions. Hologic serves healthcare providers across the United States, Europe, Asia-Pacific, and international markets through direct sales forces and independent distributors. Founded in 1985 and headquartered in Marlborough, Massachusetts, the company is committed to enabling early detection and treatment across the continuum of women's health.
